
European Journal of Medicinal Chemistry p. 619 - 622 (1989)
Update date:2022-08-03
Topics:
Chapleo, Christopher B.
Doxey, John C.
Myers, Peter L.
Myers, Malcolm
Smith, Colin F. C.
Stillings, Michael R.
A preliminary communication reported on the pharmacology of the potent partial α2-agonist (2-(1,4-benzodioxan-6-ylamino)-2-imidazoline, a 1,4-dioxan derivative of clonidine.Its degree of agonism/antagonism depended upon the peripheral or central α2-adrenoreceptor system studied.It was of interest to discover whether a similar substitution of the 1,4-dioxan moiety in other standard α-adrenergic agents would similary produce high affinity compounds of complex pharmacological profile.The same substitution when introduced into guanfacine, fenmetazole and tolazoline resulted in unpredictable changes in profile with a reduction in α-affinity. - α2-adrenoreceptors/antagonism/agonism/clonidine derivatives/1,4-dioxan derivatives
View MoreContact:+86-531-58668191 58668193 58668196 58661173
Address:No 55,Beixiaoxinzhuang West Street,Jinan City, Shandong Province
Shanghai Xinda Pharmaceuticals Co., Ltd.
Contact:86-21-33692333-8008
Address:999 Linxian Road, Jinshan Industrial Park, Shanghai, China
shanghai hekang chemical co.ltd
Contact:021-54173790
Address:328 WuHe Road, Building #A, 2nd Floor, Minhang, Shanghai 201109, China
Shanghai Forever Synthesis Co.,Ltd.
Contact:021-61124658
Address:Zhoukang Road,Pudong New District,Shanghai,China
Xi'an Tizan Tech & Industry Co., Ltd.
Contact:86-18629066522
Address:C3009 TANG FENG INTERNATIONAL PLAZA, NO.18 FENGHUI NAN ROAD, XI'AN HIGH TECH ZONE, 710075 CHINA.
Doi:10.1021/jo00981a018
(1972)Doi:10.1039/c29710001496
(1971)Doi:10.1248/cpb.49.525
(2001)Doi:10.1007/BF00477394
()Doi:10.1021/acs.joc.5b01618
(2015)Doi:10.1016/S0960-894X(01)00776-4
(2002)